InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe theycan do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.

Biotechnology

Health Care

InterShunt Technologies, Inc.

The St Louis office likely serves as a strategic hub for leadership and innovation within the organization.

People (2)

Jobs (0)

Other offices